ArticleInsights into imaging2026
Deep-learning computer-aided detection and classification of prostate lesions on biparametric MRI: comparison with expert readers.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the performance of a deep learning-based computer-aided detection (DL-CAD) algorithm for prostate lesion detection and classification on biparametric (bp)MRI. MATERIALS AND
methodsThis retrospective, single-center study included men undergoing 3-T MRI of the prostate for suspected prostate cancer (PCa) between July and September of 2022. Using the radiology report as the reference standard, detection performance for high-risk lesions (defined as PI-RADS ≥ 3, 4, 5) by the DL-CAD was evaluated per-patient using sensitivity, specificity, PPV, NPV and AUC; and per-lesion using sensitivity and PPV. Kappa statistics was used to assess per-patient detection and per-lesion classification of PI-RADS ≥ 3 lesions. Clinical and imaging factors associated with discordance between DL-CAD and radiology reports were assessed using Mann-Whitney, Chi-square, and Fisher's exact tests.
results442 adult males (mean age 65 ± 9 years) were assessed. Per-patient sensitivity, specificity, PPV, and NPV for detection of PI-RADS ≥ 4 and 5 lesions were 65.3%/81.2%/62.7%/82.9% and 82.1%/93.8%/65.7%/97.3%, respectively. Per-patient performance for identifying PI-RADS ≥ 3/4/5 lesions was fair-to-excellent: AUC = 0.67 (0.62-0.71)/0.75 (0.71-0.80)/0.92 (0.89-0.96). For detection of PI-RADS ≥ 4 and 5, per-lesion sensitivity was 60.4% and 78.3%, while PPV was 55.0% and 60.3%. Per-patient agreement between DL-CAD and the reference increased with higher PI-RADS scores (kappa = 0.26 (0.18-0.35)/0.46 (0.37-0.55)/0.68 (0.59-0.78)). Agreement on classification of PI-RADS ≥ 3 lesions was moderate (kappa = 0.56 (0.45-0.68)).
conclusionA pre-trained DL-CAD showed good-to-excellent per-patient performance for the detection of PI-RADS ≥ 4 lesions and moderate performance of PI-RADS ≥ 3 lesion classification. Future prospective studies validating the DL algorithm with histopathologic correlation are warranted. CRITICAL RELEVANCE STATEMENT: A deep learning computer-aided detection (DL-CAD) algorithm showed good-to-excellent per-patient performance for detection of PI-RADS ≥ 4 lesions, moderate performance of PI-RADS ≥ 3 lesion classification and high negative predictive value, which can be applied in the clinic with knowledge of its limitations. KEY POINTS: Clinical validation of deep learning computer-aided detection (DL-CAD) models for the detection and classification of prostate lesions on MRI is urgently needed. A pre-trained DL-CAD algorithm showed fair-to-excellent per-patient performance for detection of prostate lesions on biparametric MRI, with moderate performance for PI-RADS ≥ 3 lesion classification. Identification of false negatives and false positives of prostate cancer detection DL-CAD algorithms is important for future improvement and clinical deployment. A DL-CAD-based prostate cancer detection algorithm with high NPV may reduce interpretation time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.